Morgan Stanley’s iShares Evolved U.S. Innovative Healthcare ETF IEIH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,265
Closed -$106K 7884
2021
Q1
$106K Buy
3,265
+1,500
+85% +$49.9K ﹤0.01% 5974
2020
Q4
$57K Buy
+1,765
New +$55.1K ﹤0.01% 6122

Other funds holding IEIH

Morgan Stanley's IEIH Position: Q2 2021 in Review

Morgan Stanley sold out of iShares Evolved U.S. Innovative Healthcare ETF (IEIH) in Q2 2021, closing a stake of 3,265 shares — an estimated $106K sold.

Morgan Stanley first reported a position in IEIH in Q4 2020 and held it in 2 quarters. The position peaked at $106K in Q1 2021. 15 funds tracked by Wall St. Rank hold IEIH as of Q2 2021.

  • Morgan Stanley reported no remaining iShares Evolved U.S. Innovative Healthcare ETF position as of Q2 2021 after selling out during the quarter.
  • Morgan Stanley sold 3,265 iShares Evolved U.S. Innovative Healthcare ETF shares in Q2 2021, an estimated $106K.
  • Morgan Stanley first reported a position in iShares Evolved U.S. Innovative Healthcare ETF in Q4 2020 and held it in 2 quarters.
  • Morgan Stanley's iShares Evolved U.S. Innovative Healthcare ETF position peaked at $106K in Q1 2021.
  • 15 funds tracked by Wall St. Rank held iShares Evolved U.S. Innovative Healthcare ETF as of Q2 2021.

Based on Morgan Stanley's 13F filing for Q2 2021, filed 16 Aug 2021.